Predict your next investment

Venture Capital
proximavc.com

See what CB Insights has to offer

Investments

31

About Proxima Ventures

Proxima Ventures is dedicated to improving the health and lives of people around the world by investing in emerging global healthcare technologies in a number of areas that impact human health and sustainability, including biotechnologies, therapies, medical devices, diagnosis, clinically significant digital healthcare solutions, advanced data analysis platforms, and creative business models in China healthcare system reform.

Proxima Ventures Headquarter Location

1709, Building B, Far East International Plaza No. 317 Xianxia Road

Shanghai, Shanghai,

China

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Proxima Ventures News

Proxima Ventures, Co-win Ventures invest in Bioelectronica to accelerate pharmaceutical discovery and development

Feb 10, 2021

Proxima Ventures, Co-win Ventures invest in Bioelectronica to accelerate pharmaceutical discovery and development Published: 09-02-2021 08:47:00 | By: Pie Kamau | hits: 64 | Tags: Bioelectronica announced the closing of an investment by Proxima Ventures and Co-win Ventures to advance the company's innovations in digital biochemistry, from novel assay development to scalable electrofluidics. The Series A investment was led by Proxima Ventures with follow-on investment by Co-win Ventures. The team at Proxima, experienced investors in biotech and medical devices, are headed up by Founding Partners Luke Sun and George Li. Contributing to earlier financing with Co-win, whose healthcare practice is led by Xin Huang, were Intuitive Private Equity and Rising Tide VC. With this new round of financing, Bioelectronica says it plans to expand the team, drive new applications in cell line development and antibody discovery for the Hypercell® platform. The capital will also be used for scaling the numbers of clients served through product sales of Hypercell, custom assay development and contract research. Jonathan Hull , Co-Founder and CEO, Bioelectronica: Bioelectronica is pleased to have Proxima Ventures and Co-win Ventures as partners as we continue to develop and launch Hypercell, our proprietary single cell sorting platform that uses computer vision, data science, and lensless imaging to enable single cell sorting assays with unprecedented throughput. Bioelectronica is enabling researchers to accelerate early identification of productive cells in antibody discovery and development using high-speed automation embedded in our patented Computer Vision Single Cell Sorting (CVSCS) system that uses proprietary algorithms and real-time analytics. By improving workflow efficiencies when Hypercell® is deployed, we have the potential to truly enable R&D teams to build their product pipelines and patents at rates not seen before." Luke Sun , Founder and Partner, Proxima Ventures: "We are excited to have this opportunity to work together with the Bioelectronica team. We believe its innovative Hypercell® platform can make significant contributions to the Biotech and Pharma industries worldwide." Xin Huang , Partner, Co-win Venture Capital: "We have been impressed with Bioelectronica's elegant and viable solutions to some of the most difficult problems researchers experience working with biologics. With Industry facing ever increasing challenges to remain competitive, step change innovations like Bioelectronica's can help maintain this edge."

Proxima Ventures Investments

31 Investments

Proxima Ventures has made 31 investments. Their latest investment was in NANOVISION as part of their Series C on November 11, 2021.

CBI Logo

Proxima Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

11/11/2021

Series C

NANOVISION

$78.24M

Yes

5

9/26/2021

Series B - II

MATRIDX

No

5

8/24/2021

Series A

MobiDrop

$23.18M

Yes

3

7/15/2021

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

2/22/2021

Series B

Subscribe to see more

$99M

Subscribe to see more

10

Date

11/11/2021

9/26/2021

8/24/2021

7/15/2021

2/22/2021

Round

Series C

Series B - II

Series A

Seed VC

Series B

Company

NANOVISION

MATRIDX

MobiDrop

Subscribe to see more

Subscribe to see more

Amount

$78.24M

$23.18M

$99M

$99M

New?

Yes

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

5

5

3

10

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.